SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4.41 |
| Enterprise Value ($M) | -0.45 |
| Book Value ($M) | 4.04 |
| Book Value / Share | 1.32 |
| Price / Book | 1.09 |
| NCAV ($M) | 3.58 |
| NCAV / Share | 1.17 |
| Price / NCAV | 1.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.27 |
| Return on Assets (ROA) | -1.77 |
| Return on Equity (ROE) | -3.67 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.15 |
| Current Ratio | 2.15 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.73 |
| Assets | 7.18 |
| Liabilities | 3.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.02 |
| Operating Income | -11.85 |
| Net Income | -7.44 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -8.61 |
| Cash from Investing | -0.01 |
| Cash from Financing | 6.49 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,548 | 27,364 | 60.47 | |
| 2,228 | 12,706 | 17.54 | |
| 16,522 | 41,989 | 39.35 | |
| 15,234 | 110,843 | 13.74 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SNSE – Sensei Biotherapeutics, Inc. | SNTI – Senti Biosciences, Inc. |
| SNYR – Synergy CHC Corp. | SPRB – Spruce Biosciences, Inc. |
| SRZN – Surrozen, Inc. |
Financial data and stock pages provided by
Fintel.io